Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811. Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 1 Matthew R. Golden, MD, MPH and Matthew Hogben, PhD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-715. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary Nov 2008 Ethics of Expedited Partner Therapy, Commentary 2 Mark A. Levine, MD Using expedited partner therapy to treat certain STDs entails clinical and ethical risks and benefits. Virtual Mentor. 2008;10(11):708-718. doi: 10.1001/virtualmentor.2008.10.11.ccas3-0811.
Case and Commentary May 2024 Should Antimicrobial Resistance Limit Access to an Organ Transplant? Andrew Courtwright, MD, PhD This article discusses fiduciary obligations transplant programs might have to patients with B cenocepacia. AMA J Ethics. 2024;26(5):E367-372. doi: 10.1001/amajethics.2024.367.